XML 36 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Research and development

 

$

25,439

 

 

$

22,351

 

 

$

45,600

 

 

$

39,282

 

General and administrative

 

 

15,422

 

 

 

14,049

 

 

 

29,437

 

 

 

24,373

 

Total

 

$

40,861

 

 

$

36,400

 

 

$

75,037

 

 

$

63,655

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s RSU activity for the six months ended June 30, 2024:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Unvested restricted stock units as of December 31, 2023

 

 

4,041,753

 

 

$

50.40

 

Granted

 

 

3,042,554

 

 

 

34.20

 

Vested

 

 

(1,211,234

)

 

 

51.67

 

Cancelled

 

 

(501,576

)

 

 

44.28

 

Unvested restricted stock units as of June 30, 2024

 

 

5,371,497

 

 

$

41.51

 

 

Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Weighted average assumptions used to apply this pricing model were as follows:

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2024

 

2023

 

2024

 

2023

Risk-free interest rate

 

4.3%

 

4.1%

 

4.2%

 

4.4%

Expected term

 

5.6 years

 

5.6 years

 

6.0 years

 

6.0 years

Expected volatility of underlying stock

 

76.3%

 

78.8%

 

76.4%

 

78.7%

Expected dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%

Summary of Stock Option Activity

The following is a summary of stock option activity for the six months ended June 30, 2024:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price per
Share

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at December 31, 2023

 

 

5,458,999

 

 

$

50.38

 

 

 

6.65

 

 

$

35,922

 

Granted

 

 

772,191

 

 

 

31.86

 

 

 

 

 

 

 

Exercised

 

 

(190,246

)

 

 

16.49

 

 

 

 

 

 

 

Forfeited

 

 

(331,773

)

 

 

77.99

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

5,709,171

 

 

$

47.40

 

 

 

6.30

 

 

$

15,820

 

Exercisable at June 30, 2024

 

 

4,290,920

 

 

$

45.38

 

 

 

5.51

 

 

$

15,812

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted

The fair value of shares under the 2016 Plan was estimated at the beginning of the offering period using a Black-Scholes option-pricing model with the following assumptions:

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2024

 

2023

 

2024

 

2023

Risk-free interest rate

 

5.24%

 

4.70%

 

5.24%

 

4.70%

Expected term

 

0.5 years

 

0.5 years

 

0.5 years

 

0.5 years

Expected volatility of underlying stock

 

56.7%

 

69.2%

 

56.7%

 

69.2%

Expected dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%